-- Strategic Partnership Strengthens Gilead’s Inflammation Research Portfolio with the Addition of LEO Pharma’s Preclinical Oral STAT6 Program, Including Targeted Protein Degraders -- -- Gilead Will ...
Telesat announced today that the two teams it contracted with to develop system designs for Telesat’s global low earth orbit (LEO) satellite constellation have successfully completed the System ...
Leo Pharma’s tralokinumab has hit all the primary and secondary endpoints in its three pivotal trials. The data position Leo to file for approval of the Dupixent rival in atopic dermatitis next year, ...
“Please don’t anyone try to lecture me on the commission’s supposed efficiency and timeliness in conducting auctions,” FCC Commissioner Michael O'Rielly said Sept. 24 at the 8th Annual Americas ...
LANSING, Mich. (WNEM) – The Michigan Department of Labor and Economic Opportunity (LEO) is launching a $238 million grant program to provide high-speed internet to unserved locations throughout the ...
The Hechinger Report covers one topic: education. Sign up for our newsletters to have stories delivered to your inbox. Consider becoming a member to support our nonprofit journalism. For almost as ...
ST. LEO, Fla. — "Military Times" ranked Saint Leo University first in the nation in the "Online & Nontraditional Schools" category in its "Best for Vets: Colleges 2020" list. Saint Leo University ...
(RTTNews) - Gilead Sciences, Inc. (GILD) and LEO Pharma entered strategic partnership to develop and commercialize LEO Pharma's small molecule oral STAT6 (signal transducer and activator of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback